Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Identifiable Intangible Assets Carrying Value

The net carrying value of the identifiable intangible assets as of December 31, 2019 and December 31, 2018 is as follows:

		As of December 31, 2019			As of December 31, 2018
	Life	Carrying			Carrying
	(Years)	Amount			Amount
Asuragen acquisition:
Thyroid	9	$	8,519		$	8,519
RedPath acquisition:
Pancreas test	7		16,141			16,141
Barrett’s test	9		18,351			18,351
BioPharma acquisition:
Trademarks	10		1,600			-
Customer relationships	8		5,700			-
CLIA Lab	2.3	$	609		$	609
Total		$	50,920		$	43,620
Accumulated Amortization		$	(17,419	)	$	(13,767	)
Net Carrying Value		$	33,501		$	29,853

Schedule of Goodwill Carrying Value

The following table displays a roll forward of the carrying amount of goodwill from January 1, 2018 to December 31, 2019:

	Carrying
	Amount
Balance as of January 1, 2018	$	-
Balance as of December 31, 2018		-
Goodwill acquired		8,273
Adjustments		160
Balance as of December 31, 2019	$	8,433

Schedule of Future Estimated Amortization Expense

Amortization expense was approximately $3.7 million and $3.3 million for the years ended December 31, 2019 and 2018, respectively. Estimated amortization expense for the next five years is as follows:

2020		2021		2022		2023		2024
$	5,145	$	5,781	$	3,859	$	3,859	$	3,149